|
Most recently, Dr. Antonaccio served as the Chief Scientific Officer for Phoenix Drug Discovery and Lion Pharmaceuticals. Prior to that, in his role as Vice President, Strategic Drug Development for Human Genome Science, he was responsible for organizing discovery efforts for proteins of interest and for preclinical and clinical development of selected compounds. He served a number of years at the Bristol-Myers Squibb Research Institute in various capacities, including Senior Vice President for Cardiovascular Research and Development as well as Director of Pharmacology at Squibb. Dr Antonaccio previously served as Vice President for New Drug Discovery at Schering Corp. Throughout his career, he has managed large groups of biologists, chemists and clinicians in the drug discovery and development field. Dr. Antonaccio received a B.S. in Pharmacy from Duquesne University and a Ph.D. in Pharmacology from the University of Michigan | 